Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice.

Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Abstract Text:

    naghma khanNaghma Khan,farrukh afaqFarrukh Afaq,mee-hyang kweonMee-Hyang Kweon,kyungmann kimKyungmann Kim,hasan mukhtarHasan Mukhtar,

    To develop novel mechanism-based preventive approaches for lung cancer, we examined the effect of oral consumption of a human achievable dose of pomegranate fruit extract (PFE) on growth, progression, angiogenesis, and signaling pathways in two mouse lung tumor protocols. Benzo(a)pyrene [B(a)P] and N-nitroso-tris-chloroethylurea (NTCU) were used to induce lung tumors, and PFE was given in drinking water to A/J mice. Lung tumor yield was examined on the 84th day and 140 days after B(a)P dosing and 240 days after NTCU treatment. Mice treated with PFE and exposed to B(a)P and NTCU had statistically significant lower lung tumor multiplicities than mice treated with carcinogens only. Tumor reduction was 53.9% and 61.6% in the B(a)P + PFE group at 84 and 140 days, respectively, compared with the B(a)P group. The NTCU + PFE group had 65.9% tumor reduction compared with the NTCU group at 240 days. Immunoblot analysis and immunohistochemistry were used to determine effect on cell survival pathways and markers of cellular proliferation and angiogenesis. PFE treatment caused inhibition of (a) activation of nuclear factor-kappaB and IkappaBalpha kinase, (b) degradation and phosphorylation of IkappaBalpha, (c) phosphorylation of mitogen-activated protein kinases (extracellular signal-regulated kinase 1/2, c-Jun NH(2)-terminal kinase 1/2, and p38), (d) phosphatidylinositol 3-kinase (p85 and p110), (e) phosphorylation of Akt at Thr(308), (f) activation of mammalian target of rapamycin signaling, (g) phosphorylation of c-met, and (h) markers of cell proliferation (Ki-67 and proliferating cell nuclear antigen) and angiogenesis (inducible nitric oxide synthase, CD31, and vascular endothelial growth factor) in lungs of B(a)P- and NTCU-treated mice. Thus, our data show that PFE significantly inhibits lung tumorigenesis in A/J mice and merits investigation as a chemopreventive agent for human lung cancer.

    Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Publishing Authors By Initials

    n khanN Khan,f afaqF Afaq,mh kweonMH Kweon,k kimK Kim,h mukhtarH Mukhtar,

    For similar organic chemicals: urea research abstracts see: organic chemicals: urea research

    PUBMED ID PMID:

    MEDLINE DATE:

    Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Cancer research

    VOLUME: 67

    Page Numbers: 3475-82

    Journal Abbreviation:

    ISSN: 0008-5472

    DAY: 27

    MONTH: 03

    YEAR: 2007

    Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 2984705

    Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Keywords Mesh Terms:

    KEYWORDS: Urea

    MESH TERMS: analogs & derivatives

    Chemical & Substance for Abstract: Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Information

    Substance Name: Proto-Oncogene Proteins c-akt

    Registry Number: EC 2.7.1.37

    Grant and Affiliation Information for Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice.

    AFFILIATION: Department of Dermatology and Biostatistics and Medical Informatics, University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: R01 CA78809

    ACRONYM: CA

    MEDLINETA: Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News